Craft

Dogwood Therapeutics

Stock Price

$4.5

2024-10-29

Market Capitalization

$206.5 K

2024-10-29

Dogwood Therapeutics Summary

Company Summary

Overview
Dogwood Therapeutics (formerly known as Virios Therapeutics and Innovative Med Concepts) is a biotechnology company focused on antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response. It offers therapeutic candidates designed to address conditions, such as chemotherapy-induced neuropathy, fibromyalgia, and post-viral fatigue.
Type
Public
Status
Active
Founded
2012
HQ
Alpharetta, GA, US | view all locations
Website
https://www.dwtx.com/
Cybersecurity rating
Sectors

Key People

  • Greg Duncan

    Greg Duncan, Chief Executive Officer & Chairman of the Board of Directors

  • Ralph Grosswald

    Ralph Grosswald, Senior Vice President of Operations

  • R. Michael Gendreau

    R. Michael Gendreau, Chief Medical Officer

  • Angela Walsh

    Angela Walsh, Chief Financial Officer, Secretary & Treasurer

LocationsView all

1 location detected

  • Alpharetta, GA HQ

    United States

    44 Milton Ave

Dogwood Therapeutics Financials

Summary Financials

Net income (Q1, 2026)
($5.0M)
Cash (Q1, 2026)
$13.2M
EBIT (Q1, 2026)
($5.1M)
Enterprise value
($12.9M)

Footer menu